Our CEO Christopher Hart is at #MedInvest2024! Learn about how our AI-enabled platform decodes rules for safer, quicker OBM development, overcoming delivery challenges with targeted aptamers to reach specific cells and tissues. Discover how our approach has recently translated into positive clinical outcomes. https://lnkd.in/dusxNE3 #AIinHealthcare #DrugDelivery?
Creyon Bio的动态
最相关的动态
-
Accomplished business development executive with focus on bringing new technologies to market.
Do you want to see how Indica Labs is helping digital pathology adoption in a clinical environment? If so, check out this webinar. #digitalpathology #efficiency
Don't miss our collaborative webinar with Pathology News exploring how our HALO AP platforms with regulatory clearances can be used for comprehensive workflows in primary diagnostics! Join Katie McKinley, our VP of Clinical Applications, on Oct. 10 to see how HALO AP platforms: ? automatically organize images, metadata, gross details, and patient information into cases ? facilitate case prioritization and sign-out ? enable ergonomic image navigation ? and much more For all the information and registration: https://lnkd.in/gZGcyP_r #DigitalPathology #TissueAnalysis #PathologyLabs #HALOap #HALOapDx #IndicaLabs
-
"We want to be able to do in human tissue what we do in mice, which is we reiterate and refine." Andrei Georgescu, Ph.D., Vivodyne cofounder and CEO, spoke about drug discovery at the 2024 Forbes Healthcare Summit. #ForbesHealth https://lnkd.in/ekZiQXJf
-
Merge & Grow? is the solution to boost your practice revenue! Collaborating with the GoPath Diagnostics team, we have a proven track record of adding to your bottom line. Let's chat today about the latest innovation for pathology practices! #MergeAndGrow #GoPathDiagnostics #PracticeRevenue #Innovation
-
-
EfA Technologies is revolutionizing on-site #blood diagnostics with RevDx, EFA’s flagship product. RevDx is a sophisticated portable diagnostic device that leverages advanced technology to provide accurate and rapid medical blood testing locally. Its capabilities include identifying pathogens, analyzing biomarkers and aiding in disease diagnosis. EFA today announces having entered the promising Brazilian market. RevDx marks a significant breakthrough in medical diagnostics. It is portable, affordable and user-friendly, leveraging microscopy and AI to deliver instant results. This not only reduces costs and saves time, but also improves the doctor-patient relationship. With the capability to perform a full CBC count from just a single drop of blood, the device streamlines diagnostics and equips healthcare professionals with actionable insights. Read the full press release here: https://lnkd.in/erJcNURU #HealthInnovations #health #medtech #blood #diagnostics #brasil
-
-
Make sure to join the next ASPHO webinar TOMORROW at 3pm CT! Learn about the effects of Sirolimus on patients with vascular anomalies with speakers #JoanaMack, MD, and #BhuvanaSetty, MD, and moderator #TaizoNakano, MD. Register today: https://ow.ly/5hp250TJYYX #PHODocs #PedsHemeOnc #sirolimus #webinar
-
-
Check it Out ?? Our CEO dives into the transformative impact of MolecuLight's fluorescence imaging on wound outcomes and antibiotic prescriptions in long-term care facilities! ?? #InnovativeHealthcare #WoundCareRevolution ??#WCP #WoundCarePlus
-
-
“Rapid advancements in AI are unlocking new sources of value for digitization in the precision medicine paradigm at an unprecedented pace. We look forward to helping our customers continue to capitalize and elevate their role in the future of healthcare.” - Proscia CEO David West on our recent honors from CB Insights
We're incredibly proud to share that CB Insights named us to its 2024 #DigitalHealth50 AND has us in the leadership position of its diagnostic digital pathology market landscapes. ???? Read the full press release: https://bit.ly/3ZGmYBv To our Proscians, thank you for your tireless contribution to our mission. Way to 'win as a team' and 'raise the bar!' All of our recognition over the past few weeks is a direct reflection of all that you do. #DH50 #digitalpathology
-
Our Director of Innovation Engineering, Scott Leonard joined us for #HYPERACT Part II to discuss the importance of cannula design and how the internal diameter size of the cannula affects patient therapy. This video is from our webinar HYPERACT Part II – Why Cannula Design Matters, coming to #VapothermAcademy August 1st!
-
Discover the latest issue of The Volpi Voice! This edition highlights the integration of #multimodal platforms for #invitrodiagnostics at the point of care, as well as an introduction to #multiomics for #precisionmedicine. Get your copy of The Volpi Voice today!" #POCT #genomics #proteomics #transcriptomics #metabolomics #
?? The Volpi Voice is here! ?? The newest edition of The Volpi Voice is here, brimming with impactful stories and updates. ?? Volpi’s 70-Year Celebration and Beyond ?? Join us as we commemorate 70 years of dedicated service! Get a glimpse of our vision for the coming years as we continue pushing the boundaries of diagnostic technology. ?? Revolutionizing #IVD: #Multimodal Platforms at the Point of Care ?? Explore how multimodal IVD platforms are transforming diagnostics at the point of care. We take you behind the scenes to learn about the latest advances and the real-world impact of integrated diagnostics. ?? Multi-Omics: Precision Medicine in Action ?? See how multi-omics is redefining healthcare by integrating diverse biological data, paving the way for personalized medicine and early disease detection. ???? Meet Volpi's Head of R&D, Francisco Faoro ???? Gain an insider’s view into the world of R&D at Volpi with Francisco Faoro. Discover how our R&D team brings complex concepts to life and develops solutions that address critical medical needs. Catch up on the latest from Volpi and join the conversation on the future of diagnostics. Read The Volpi Voice now! #volpigroup #lightinsightlife #thevolpivoice #ivd #multimodalplatforms #multiomics #pointofcare https://lnkd.in/ebVJGPid
-
-
???? Lucid Diagnostics joins forces with VITALExam to offer EsoGuard test to firefighters VITALExam, led by CEO Marci Vitale, is a medical care provider for first responders. The company offers a range of services, including cancer screenings, comprehensive physicals, and behavioural health assessments. VITALExam utilises advanced technology and evidence-based practices to deliver care focused on optimising the wellness of first responders. This collaboration supports Lucid Diagnostics’ expanded direct contracting initiative to drive near-term EsoGuard revenue. Read more online: https://lnkd.in/e5iq5f4E ?? Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing
-
